Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Management of Reference Standards and Working Standards – V 2.0

Posted on By

Analytical Method Development: SOP for Management of Reference Standards and Working Standards – V 2.0

Standard Operating Procedure for Management of Reference and Working Standards in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/318/2025
Supersedes SOP/AMD/318/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define the standardized process for the management of reference standards (RS) and working standards (WS) in

the Analytical Method Development (AMD) department. This includes procurement, qualification, labelling, storage, usage, requalification, and destruction to ensure data integrity and regulatory compliance.

2. Scope

This SOP applies to all reference and working standards used for method validation, transfer, and stability studies conducted within the AMD department, including pharmacopoeial, certified, or in-house developed standards.

3. Responsibilities

  • Analyst: Requests, uses, and records the usage of standards in the analytical worksheet.
  • AMD Documentation Officer: Maintains logbooks for receipt, qualification, and requalification.
  • QA Representative: Verifies documentation and compliance with SOP and regulatory guidelines.
  • Stores Personnel: Assists in controlled storage and tracking of standard stock.
See also  Analytical Method Development: Residual Solvent Estimation by HPLC - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring compliance with procedures for handling, tracking, and using reference and working standards within the department.

5. Procedure

5.1 Procurement and Receipt

  1. Reference standards shall be procured from pharmacopeial sources (e.g., USP, EP, BP) or certified manufacturers.
  2. Working standards may be prepared in-house using qualified batches and compared with certified RS.
  3. On receipt, verify the Certificate of Analysis (CoA), batch number, expiry, and manufacturer details.
  4. Log receipt details in Reference Standard Register (Annexure-1).

5.2 Labelling and Identification

  1. Each container must be labeled with the name, batch number, received date, expiry/re-test date, and storage conditions.
  2. Labels must also include the unique RS/WS ID number for traceability.

5.3 Qualification and Approval

  1. Perform identity, assay, and purity checks for in-house WS by comparing it against certified RS.
  2. Prepare a Working Standard Qualification Report (Annexure-2) including raw data and comparison results.
  3. Obtain approval from QA prior to use.

5.4 Storage and Inventory Control

  1. Store standards in temperature-controlled refrigerators or desiccators based on label instructions.
  2. Maintain an inventory log for RS and WS, updating it with each issuance (Annexure-3).
  3. Conduct periodic checks to ensure standard integrity and prevent usage beyond expiry.
See also  Analytical Method Development: Integration with Product Development Team - V 2.0

5.5 Usage and Documentation

  1. Standards should be brought to room temperature before use and returned immediately after use.
  2. Record quantity used, analyst name, date, and purpose in the Standard Usage Log (Annexure-4).
  3. Ensure cumulative usage does not exceed predefined quantity thresholds.

5.6 Requalification and Expiry

  1. Conduct requalification prior to re-test date by evaluating critical parameters.
  2. If RS or WS fails requalification, immediately withdraw it from use and label as “Expired.”
  3. Prepare Requalification Summary and submit to QA for final disposition.

5.7 Destruction and Disposal

  1. Expired or failed standards should be destroyed under supervision as per hazardous waste disposal SOP.
  2. Document destruction details in Annexure-5 and obtain QA approval.

6. Abbreviations

  • RS: Reference Standard
  • WS: Working Standard
  • CoA: Certificate of Analysis
  • QA: Quality Assurance

7. Documents

  1. Reference Standard Register – Annexure-1
  2. Working Standard Qualification Report – Annexure-2
  3. Standard Inventory Log – Annexure-3
  4. Standard Usage Log – Annexure-4
  5. Destruction Record – Annexure-5

8. References

  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
  • WHO Technical Report Series 992 – Good Practices for Pharmaceutical Quality Control Laboratories
  • 21 CFR Part 211.84 – Testing and Approval of Components
See also  Analytical Method Development: SOP for Osmolarity Testing of Ophthalmic Solutions - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Nikita Sharma Arun Mehta Dr. Harshita Goyal
Designation AMD Chemist QA Reviewer Head – AMD Department
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Reference Standard Register

RS ID Name Batch No. Source Received Date Expiry Status
RS-318-01 Metformin HCl MTH/USP/2025 USP 20/05/2025 20/05/2026 Active

Annexure-2: WS Qualification Report

Includes assay results, identity confirmation, RS comparison, purity check, and approval record.

Annexure-3: Standard Inventory Log

Tracks stock balance, usage trend, and minimum re-order levels.

Annexure-4: Standard Usage Log

Date Analyst Purpose Qty Used Remaining Remarks
25/05/2025 Amit R. Assay Validation 50 mg 450 mg Logged

Annexure-5: Destruction Record

Details of quantity destroyed, mode of destruction, witness signatures, and justification for disposal.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded requalification and labeling guidelines Annual SOP Review Dr. Harshita Goyal
12/08/2022 1.0 Initial SOP Release New SOP Implementation QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Water Content Determination (Karl Fischer) – V 2.0
Next Post: Elixir Department: SOP for Endotoxin Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version